Goldplat PLC (GDP)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 22.80 |
|---|---|
| 52-week range | 7.66 – 27.00 |
| Return, 1 month / 3 months | +19.0% / +30.3% |
| Return, 1 year / 3 years | +162.5% / +313.6% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 51.3% |
| Worst drawdown (1 year) | -17.5% |
| Average daily value traded | 12.77M GBX |
| Dividend yield | 6.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Goldplat PLC is a United Kingdom based company that recovers gold and other precious metals from by-products and waste materials generated by mining operations. Its recovery plants in South Africa and Ghana process materials such as mill liners, wood chips and fine carbon to extract residual gold. The company also owns and operates a gold mine in Kenya, where it explores for and produces gold. Its customers are mainly mining companies and metal refiners.
On this site Goldplat PLC appears as a stock on the London Exchange (UK), code GDP, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Goldplat PLC (GDP) trades on the London Exchange in UK. It last closed at GBX 22.80 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 266 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 162.5% and over the last three months it rose 30.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 51.5% | ||
| From 52-week high | -10.9% | ||
| Momentum | 96 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 30.3% | ||
| 6-month return | 62.3% | ||
| 12-month return, skipping the last month | 120.5% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 51.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.5% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 12.77M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.8% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +11.2% |
|---|---|
| 1 month | +19.0% |
| 3 months | +30.3% |
| 6 months | +62.3% |
| 1 year | +162.5% |
| 3 years | +313.6% |
| 5 years | +243.2% |
Signals
| 50-day / 200-day average | 18.81 / 15.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Oct 2026 | GBP 0.0087 |
| 27 Aug 2026 | GBP 0.0023 |
| 28 May 2026 | GBP 0.0018 |
| 19 Feb 2026 | GBP 0.0015 |
| 4 Dec 2025 | GBP 0.0012 |
| 14 Aug 2025 | GBP 0.0009 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.